Within the University of Antwerp, MICA is actively involved in a broad range of multi-disciplinary collaborative research projects at both the national and international levels.
In close collaboration with , new innovative radiopharmaceutical solutions are being developed aimed at improving the diagnosis and treatment of cancer patients.
MICA contributes to the development of diagnostic biomarkers and therapeutic strategies intended to provide meaningful clinical benefits for patients with Huntington's disease, in partnership with the .
Together with the Bio Imaging Lab, we have established a CORE facility that brings together specialised expertise and state-of-the-art preclinical imaging infrastructure within the University of Antwerp
Furthermore, MICA is a member of IMARK, an intra-university consortium created to combine the different modalities of biomarker discovery, tracing and detection in a single hub which is aimed to facilitate industry interaction and participation to large-scale European research projects.